RADELUMIN Trademark

Trademark Overview


On Thursday, March 31, 2022, a trademark application was filed for RADELUMIN with the United States Patent and Trademark Office. The USPTO has given the RADELUMIN trademark a serial number of 79348236. The federal status of this trademark filing is REGISTERED as of Tuesday, December 12, 2023. This trademark is owned by ABX advanced biochemical compounds - Biomedizinische Forschungsreagenzien GmbH. The RADELUMIN trademark is filed in the Pharmaceutical Products category with the following description:

Medical and veterinary preparations for the diagnosis of diseases of the prostate; medical and veterinary preparations for the treatment of diseases of the prostate; medical and veterinary preparations for the diagnosis of cancer; medical and veterinary preparations for the treatment of cancer; dietetic foods and beverages adapted for medical or veterinary purposes; chemical preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the diagnosis of cancer; chemical preparations for medical or pharmaceutical purposes for the treatment of cancer; biological preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; biological preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; biological prep...
radelumin

General Information


Serial Number79348236
Word MarkRADELUMIN
Filing DateThursday, March 31, 2022
Status700 - REGISTERED
Status DateTuesday, December 12, 2023
Registration Number7238476
Registration DateTuesday, December 12, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 26, 2023

Trademark Statements


Goods and ServicesMedical and veterinary preparations for the diagnosis of diseases of the prostate; medical and veterinary preparations for the treatment of diseases of the prostate; medical and veterinary preparations for the diagnosis of cancer; medical and veterinary preparations for the treatment of cancer; dietetic foods and beverages adapted for medical or veterinary purposes; chemical preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the diagnosis of cancer; chemical preparations for medical or pharmaceutical purposes for the treatment of cancer; biological preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; biological preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; biological preparations for medical or pharmaceutical purposes for the diagnosis of cancer; biological preparations for medical or pharmaceutical purposes for the treatment of cancer; preparations for use in medical diagnostic processes, namely, diagnostic preparations for medical purposes; preparations for use in medical diagnostic processes, namely, diagnostic preparations for medical purposes relating to the diagnosis of diseases of the prostate; preparations for use in medical diagnostic processes, namely, diagnostic preparations for medical purposes relating to the diagnosis of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 31, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameABX advanced biochemical compounds - Biomedizinische Forschungsreagenzien GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameABX advanced biochemical compounds - Biomedizinische Forschungsreagenzien GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameABX advanced biochemical compounds - Biomedizinische Forschungsreagenzien GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Friday, March 15, 2024GENERIC MADRID TRANSACTION SENT TO IB
Friday, March 15, 2024GENERIC MADRID TRANSACTION CREATED
Tuesday, March 12, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 12, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 12, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, September 26, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 26, 2023PUBLISHED FOR OPPOSITION
Monday, September 25, 2023NOTIFICATION PROCESSED BY IB
Wednesday, September 6, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 6, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 6, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 13, 2023REFUSAL PROCESSED BY IB
Friday, March 17, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, March 16, 2023REFUSAL PROCESSED BY MPU
Wednesday, January 25, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, January 24, 2023NON-FINAL ACTION WRITTEN
Wednesday, January 18, 2023ASSIGNED TO EXAMINER
Tuesday, September 6, 2022APPLICATION FILING RECEIPT MAILED
Wednesday, August 31, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 30, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 25, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB